Assert-IQ vs FEops HEARTguide

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

Assert-IQ

by Abbott

FEops HEARTguide

by FEops

AI Verdict

Assert-IQ is designed for long-term, continuous cardiac monitoring and arrhythmia detection to aid in diagnosing and managing heart rhythm disorders. In contrast, FEops HEARTguide focuses on pre-operative planning for structural heart procedures, utilizing predictive simulations and digital twin technology to optimize device sizing and positioning. While both are cardiology AI tools, they address distinct phases and types of cardiac care.

Choose Assert-IQ if…

Choose Assert-IQ if your primary need is long-term, continuous cardiac monitoring for patients with suspected or intermittent heart rhythm disorders. This system is ideal for comprehensive arrhythmia detection over several years, enabling remote monitoring and proactive alerts for clinicians to diagnose and manage conditions effectively.

View Assert-IQ →

Choose FEops HEARTguide if…

Choose FEops HEARTguide if you require advanced pre-operative planning and optimization for structural heart procedures. This platform excels at providing predictive simulations and patient-specific digital twins to accurately assess anatomical measurements and determine optimal device sizing and positioning before intervention.

View FEops HEARTguide →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	Assert-IQ	FEops HEARTguide
Deployment	Subcutaneously implanted device with mobile app connectivity	Cloud Based platform
FDA Status	Cleared AI-estimated	Cleared AI-estimated
HIPAA	Unknown	Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

FEops HEARTguide

FEops HEARTguide offers a fully cloud-based platform with anytime, anywhere access, a DICOM interface for CT scan upload, and interactive 2D/3D viewers, providing a comprehensive and flexible user experience for clinicians. Assert-IQ, while offering remote monitoring, lacks a dedicated mobile app and its clinician interface details are less specified for direct interactive use.

Clinical Value

FEops HEARTguide

FEops HEARTguide's predictive simulation and digital twin technology for pre-operative planning directly optimize device sizing and positioning in complex structural heart procedures, potentially leading to improved patient outcomes and reduced complications. Assert-IQ provides significant value in long-term arrhythmia diagnosis and management, but FEops HEARTguide's direct impact on interventional success gives it a slight edge in critical care pathways.

Pricing & Value

Tie

Both tools employ opaque pricing models, requiring direct contact for institutional pricing, and neither offers a free trial. Without specific cost information or detailed return on investment (ROI) data, it is not possible to definitively compare their pricing and value propositions.

Enterprise Readiness

Assert-IQ

Abbott Medical, a long-established global medical device company, provides Assert-IQ with a strong foundation for enterprise readiness, including robust support infrastructure, established integration pathways, and long-term organizational stability. While FEops HEARTguide is FDA cleared and HIPAA compliant with cloud deployment and DICOM integration, Abbott's scale and history offer a more comprehensive enterprise solution.

Innovation

FEops HEARTguide

FEops HEARTguide's utilization of digital twin technology and predictive simulations for patient-specific pre-operative planning represents a more novel and cutting-edge application of AI in healthcare, pushing the boundaries of personalized medicine in structural heart disease. Assert-IQ offers advanced monitoring capabilities, but FEops HEARTguide's core methodology is more innovative.

Support & Docs

Assert-IQ

As a large, established global medical device company, Abbott Medical is highly likely to possess extensive support infrastructure, comprehensive documentation, and dedicated service teams for its products. While FEops NV undoubtedly provides support, the sheer scale and resources of Abbott suggest a more robust and readily available support system.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	Assert-IQ	FEops HEARTguide
Product Name	Assert-IQ	FEops HEARTguide
Company	Abbott Medical	FEops NV
Primary Use Case	Long-term, continuous monitoring and advanced arrhythmia detection to aid physicians in diagnosing and managing patients with suspected heart rhythm disorders.	Cloud-based AI and digital twin platform for structural heart procedure planning, providing predictive simulations and anatomical measurements to optimize device sizing and positioning.
Core Technology/Approach	Insertable Cardiac Monitor, Advanced arrhythmia detection algorithms, Remote monitoring capabilities	Predictive simulation technology, AI-based anatomical measurements, Digital twin technology
Target Specialties	Cardiology, Internal Medicine	Cardiology, Cardiothoracic Surgery
Categories	Cardiology AI, Clinical Decision Support & Reference	Cardiology AI, Surgical AI

Videos

Demos, reviews, and walkthroughs featuring Assert-IQ and FEops HEARTguide.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What is the primary difference in functionality between Assert-IQ and FEops HEARTguide?

Assert-IQ is an Insertable Cardiac Monitor (ICM) system designed for long-term, continuous monitoring and advanced arrhythmia detection to diagnose and manage heart rhythm disorders. In contrast, FEops HEARTguide is a cloud-based AI and digital twin platform focused on structural heart procedure planning, providing predictive simulations and anatomical measurements.

For which patient populations or clinical scenarios are these tools best suited?

Assert-IQ is best suited for patients with suspected heart rhythm disorders requiring long-term cardiac monitoring for diagnosis and management. FEops HEARTguide is designed for patients undergoing structural heart procedures, aiding in pre-operative planning to optimize device sizing and positioning.

What core technologies do Assert-IQ and FEops HEARTguide utilize?

Assert-IQ utilizes an insertable cardiac monitor system with advanced arrhythmia detection algorithms and Bluetoothu00ae Low Energy data transmission. FEops HEARTguide leverages AI, digital twin technology, and predictive simulations to create patient-specific anatomical replicas for procedure planning.

Which medical specialties are these tools designed to support?

Assert-IQ is designed to support Cardiology and Internal Medicine specialties. FEops HEARTguide is tailored for Cardiology and Cardiothoracic Surgery specialties.

Does either tool offer long-term patient management or is it focused on a specific phase of care?

Assert-IQ provides long-term continuous cardiac monitoring for up to 6 years, focusing on ongoing arrhythmia detection and management. FEops HEARTguide is focused on the pre-operative phase of care, specifically for planning structural heart procedures.

What kind of patient data do these tools utilize?

Assert-IQ collects continuous cardiac rhythm data directly from its insertable monitor. FEops HEARTguide utilizes CT scan data uploaded via a DICOM interface to perform anatomical measurements and predictive simulations.